Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study

BACKGROUND: After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients with squamous cell carcinoma (SCC). An active surveillance strategy has been proposed for SCC patients with clinically complete re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaobin, Eyck, Ben M., Yang, Yang, Liu, Jun, Chao, Yin-Kai, Hou, Ming-Mo, Hung, Tsung-Min, Pang, Qingsong, Yu, Zhen-Tao, Jiang, Hongjing, Law, Simon, Wong, Ian, Lam, Ka-On, van der Wilk, Berend J., van der Gaast, Ate, Spaander, Manon C. W., Valkema, Roelf, Lagarde, Sjoerd M., Wijnhoven, Bas P. L., van Lanschot, J. Jan B., Li, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060643/
https://www.ncbi.nlm.nih.gov/pubmed/32143580
http://dx.doi.org/10.1186/s12885-020-6669-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060643/
https://www.ncbi.nlm.nih.gov/pubmed/32143580
http://dx.doi.org/10.1186/s12885-020-6669-y

Ejemplares similares